Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - KEMPHARM, INC | kmph20171231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex_104680.htm |
| EX-32.1 - EXHIBIT 32.1 - KEMPHARM, INC | ex_104679.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex_104678.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex_104676.htm |
| EX-23.2 - EXHIBIT 23.2 - KEMPHARM, INC | ex_108732.htm |
| EX-10.27 - EXHIBIT 10.27 - KEMPHARM, INC | ex_106556.htm |
| EX-10.14 - EXHIBIT 10.14 - KEMPHARM, INC | ex_108319.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No. 333-213926) on Form S-3 and Registration Statement (No. 333-203703, No. 333-210369 and No. 333-216858) on Form S-8 of KemPharm, Inc. of our report dated March 30, 2018, relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2017.
/s/ RSM US LLP
Orlando, Florida
March 30, 2018